Kitazato Corporation (TYO:368A)

Market Cap	55.76B
Revenue (ttm)	10.98B +8.9%
Net Income	3.98B +0.3%
EPS	99.60 +0.3%
Shares Out	40.00M
PE Ratio	14.00
Forward PE	14.03
Dividend	41.00 (2.94%)
Ex-Dividend Date	n/a

Volume	147,200
Average Volume	128,275
Open	1,365.00
Previous Close	1,376.00
Day's Range	1,362.00 - 1,398.00
52-Week Range	1,305.00 - 2,158.00
Beta	n/a
RSI	45.81
Earnings Date	May 22, 2026

About Kitazato

Kitazato Corporation researches, develops, manufactures, and markets medical devices and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation is a subsidiary of Kitasato Shoji Co., Ltd.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 86
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 368A

Financial Performance

In fiscal year 2025, Kitazato's revenue was 10.30 billion, an increase of 2.20% compared to the previous year's 10.08 billion. Earnings were 3.79 billion, a decrease of -4.63%.